Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Queensland Health
Daiichi Sankyo
Chinese Patent Office
Farmers Insurance
Cipla
Cerilliant
Healthtrust
Johnson and Johnson
Cantor Fitzgerald

Generated: February 20, 2018

DrugPatentWatch Database Preview

ATHROMBIN Drug Profile

« Back to Dashboard

When do Athrombin patents expire, and when can generic versions of Athrombin launch?

Athrombin is a drug marketed by Pharm Res Assoc and is included in one NDA.

The generic ingredient in ATHROMBIN is warfarin potassium. There are twenty-two drug master file entries for this compound. Additional details are available on the warfarin potassium profile page.

US Patents and Regulatory Information for ATHROMBIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharm Res Assoc ATHROMBIN warfarin sodium TABLET;ORAL 011771-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharm Res Assoc ATHROMBIN warfarin sodium TABLET;ORAL 011771-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharm Res Assoc ATHROMBIN warfarin sodium TABLET;ORAL 011771-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharm Res Assoc ATHROMBIN-K warfarin potassium TABLET;ORAL 011771-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
UBS
US Army
Teva
Deloitte
Cerilliant
McKinsey
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot